↓ Skip to main content

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial

Overview of attention for article published in Lancet Infectious Diseases, April 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
113 news outlets
blogs
7 blogs
policy
1 policy source
twitter
399 X users
facebook
1 Facebook page
wikipedia
3 Wikipedia pages
reddit
1 Redditor

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
Published in
Lancet Infectious Diseases, April 2023
DOI 10.1016/s1473-3099(22)00660-0
Pubmed ID
Authors

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry, Olaf Valverde Mordt, Digas Ngolo Tete, Adeline Prêtre, Sophie Delhomme, Médard Ilunga Wa Kyhi, Mamadou Camara, Julie Catusse, Stefan Schneitter, Morgane Nusbaumer, Erick Mwamba Miaka, Hélène Mahenzi Mbembo, Joseph Makaya Mayawula, Mariame Layba Camara, Félix Akwaso Massa, Lewis Kaninda Badibabi, Augustin Kasongo Bonama, Papy Kavunga Lukula, Sylvain Mutanda Kalonji, Phyll Mariero Philemon, Ricardo Mokilifi Nganyonyi, Hugues Embana Mankiara, André Asuka Akongo Nguba, Vincent Kobo Muanza, Ernest Mulenge Nasandhel, Aimée Fifi Nzeza Bambuwu, Bruno Scherrer, Nathalie Strub-Wourgaft, Antoine Tarral

X Demographics

X Demographics

The data shown below were collected from the profiles of 399 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 9%
Student > Ph. D. Student 4 7%
Other 3 5%
Researcher 3 5%
Student > Master 3 5%
Other 8 14%
Unknown 32 55%
Readers by discipline Count As %
Unspecified 5 9%
Medicine and Dentistry 5 9%
Biochemistry, Genetics and Molecular Biology 4 7%
Nursing and Health Professions 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 8 14%
Unknown 30 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1156. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2024.
All research outputs
#12,519
of 25,390,970 outputs
Outputs from Lancet Infectious Diseases
#77
of 6,018 outputs
Outputs of similar age
#389
of 413,009 outputs
Outputs of similar age from Lancet Infectious Diseases
#2
of 112 outputs
Altmetric has tracked 25,390,970 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,018 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 92.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,009 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.